These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 27022133)

  • 1. Minireview: Multiomic candidate biomarkers for clinical manifestations of sickle cell severity: Early steps to precision medicine.
    Goodman SR; Pace BS; Hansen KC; D'alessandro A; Xia Y; Daescu O; Glatt SJ
    Exp Biol Med (Maywood); 2016 Apr; 241(7):772-81. PubMed ID: 27022133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.
    Pecak M; Korošec P; Kunej T
    OMICS; 2018 Jun; 22(6):392-409. PubMed ID: 29927718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minireview: Clinical severity in sickle cell disease: the challenges of definition and prognostication.
    Quinn CT
    Exp Biol Med (Maywood); 2016 Apr; 241(7):679-88. PubMed ID: 27013545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minireview: Genetic basis of heterogeneity and severity in sickle cell disease.
    Habara A; Steinberg MH
    Exp Biol Med (Maywood); 2016 Apr; 241(7):689-96. PubMed ID: 26936084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics through the lens of precision cardiovascular medicine.
    Lam SM; Wang Y; Li B; Du J; Shui G
    J Genet Genomics; 2017 Mar; 44(3):127-138. PubMed ID: 28325553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minireview: Prognostic factors and the response to hydroxurea treatment in sickle cell disease.
    Wang WC
    Exp Biol Med (Maywood); 2016 Apr; 241(7):730-6. PubMed ID: 27026724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker signatures of sickle cell disease severity.
    Du M; Van Ness S; Gordeuk V; Nouraie SM; Nekhai S; Gladwin M; Steinberg MH; Sebastiani P
    Blood Cells Mol Dis; 2018 Sep; 72():1-9. PubMed ID: 29778312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.
    Del Boccio P; Rossi C; di Ioia M; Cicalini I; Sacchetta P; Pieragostino D
    Proteomics Clin Appl; 2016 Apr; 10(4):470-84. PubMed ID: 27061322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA profile and disease severity in patients with sickle cell anemia.
    Biassi TP; Guerra-Shinohara EM; Moretti PNS; de Freitas Dutra V; Cabañas-Pedro AC; Mecabo G; Colleoni GWB; Figueiredo MS
    Ann Hematol; 2022 Jan; 101(1):27-34. PubMed ID: 34677646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative methods for analyzing big data in precision medicine.
    Gligorijević V; Malod-Dognin N; Pržulj N
    Proteomics; 2016 Mar; 16(5):741-58. PubMed ID: 26677817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity, pathobiology, epistatic effects, and genetic markers in sickle cell anemia.
    Nagel RL
    Semin Hematol; 1991 Jul; 28(3):180-201. PubMed ID: 1716002
    [No Abstract]   [Full Text] [Related]  

  • 12. Sickle cell disease severity: an introduction.
    Pace BS; Goodman SR
    Exp Biol Med (Maywood); 2016 Apr; 241(7):677-8. PubMed ID: 27190296
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-S gene cluster haplotypes modulate hematologic and hemorheologic expression in sickle cell anemia. Use in predicting clinical severity.
    Powars DR; Meiselman HJ; Fisher TC; Hiti A; Johnson C
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):55-61. PubMed ID: 7508688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics: Applications and Promise in Mycobacterial Disease.
    Mirsaeidi M; Banoei MM; Winston BW; Schraufnagel DE
    Ann Am Thorac Soc; 2015 Sep; 12(9):1278-87. PubMed ID: 26196272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.
    Yan SK; Liu RH; Jin HZ; Liu XR; Ye J; Shan L; Zhang WD
    Chin J Nat Med; 2015 Jan; 13(1):3-21. PubMed ID: 25660284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
    Tebani A; Afonso C; Marret S; Bekri S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring success: utility of biomarkers in sickle cell disease clinical trials and care.
    Kalpatthi R; Novelli EM
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):482-492. PubMed ID: 30504349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of hemoglobin and fetal hemoglobin in early kidney disease for children with sickle cell anemia.
    Lebensburger J; Johnson SM; Askenazi DJ; Rozario NL; Howard TH; Hilliard LM
    Am J Hematol; 2011 May; 86(5):430-2. PubMed ID: 21523807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proteomics and interactomics of human erythrocytes.
    Goodman SR; Daescu O; Kakhniashvili DG; Zivanic M
    Exp Biol Med (Maywood); 2013 May; 238(5):509-18. PubMed ID: 23856902
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.